SCHEMBL18853066

SCHEMBL18853066

c1ccc(-c2nc(-n3c4ccccc4c4cc(-c5ccc6c(c5)c5ccccc5n6-c5ccccc5)ccc43)nc3c2sc2c4ccccc4ccc32)cc1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ CYP1A1 P04798 2/20 0.35
▸ CYP1B1 Q16678 2/20 0.35
▸ NPY5R Q15761 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MAPT P10636 1/20 0.32
▸ MAPK1 P28482 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ MMP14 P50281 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ PTGER4 P35408 1/20 0.32
▸ CYP1A2 P05177 1/20 0.31
▸ PTGES O14684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18852944 0.96 KDM4E (0.38) L3MBTL1KDM4EATMCYP1A1CYP1B1
SCHEMBL26743561 0.94 L3MBTL1 (0.38) L3MBTL1KDM4EATMCYP1A1CYP1B1
SCHEMBL19679669 0.88 KDM4E (0.35) L3MBTL1KDM4EATMNPY5RPTGER4
SCHEMBL26743811 0.88 CYP1A1 (0.36) L3MBTL1CYP1A1CYP1B1MEN1LMNA
SCHEMBL26743808 0.88 CYP1A1 (0.36) L3MBTL1CYP1A1CYP1B1NPY5RMEN1
SCHEMBL26743805 0.88 CYP1A1 (0.38) L3MBTL1CYP1A1CYP1B1NPY5RMEN1
SCHEMBL26743863 0.87 CYP1A1 (0.34) L3MBTL1KDM4EATMCYP1A1CYP1B1
SCHEMBL18852936 0.87 L3MBTL1 (0.37) L3MBTL1KDM4EATMCYP1A1CYP1B1
SCHEMBL17087600 0.87 KDM4E (0.38) L3MBTL1KDM4EATMNPY5RLMNA
SCHEMBL24479456 0.86 LIMK1 (0.36) L3MBTL1KDM4EATMNPY5RPTGER4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10680190-B2 Organic compound, organic optoelectronic element, and display device SAMSUNG SDI CO., LTD. (KR) 2020-06-09 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE SAMSUNG SDI CO.,LTD. (KR) 2017-05-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170141331-A1 ORGANIC COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE OCIAD1, OXER1, OCIAD2 L3MBTL1 3198/4885KDM4E 3232/4885ATM 4486/4885
US-10680190-B2 Organic compound, organic optoelectronic element, and display device OCIAD1, OXER1, OCIAD2 L3MBTL1 3198/4885KDM4E 3232/4885ATM 4486/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback